Airway Therapeutics
GA - Marietta
Biotechnology11 H-1B visas (FY2023)Focus: Protein therapeutics for lung disorders
Airway Therapeutics is a life sciences company focused on Protein therapeutics for lung disorders.
Respiratory
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
CRS Questionnaire Validation Project
Chronic Rhinosinusitis (CRS) With and Without Nasal PolypsClinical Trials (1)
NCT06970977CRS Questionnaire Validation Project
N/AEndoscopic dilation of subglottic stenosis
Idiopathic Subglottic Stenosis (iSGS)Clinical Trials (1)
NCT02481817Treatment Alternatives in iSGS (NoAAC PR-02 Study)
N/ABiologic drugs
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)Clinical Trials (1)
NCT06617754International Severe CRSwNP Registry 2024-2028
N/APediatric Arm of DZL All Age Asthma Cohort
AsthmaPCR
AsthmaClinical Trials (1)
NCT06286007Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
N/AAirway assessment
Granulomatosis With PolyangiitisClinical Trials (1)
NCT03182049Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study
N/AAT-100
COVID-19Clinical Trials (1)
NCT04659122A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia
Phase 1Phase 1
Clinical Trials (1)
NCT04662151A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)
Phase 1Air-sham
Bronchopulmonary DysplasiaClinical Trials (1)
NCT06897839Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Phase 2/3Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 8 clinical trials
H-1B (2023): 11 approvals
Open Roles: 1 active job
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
11
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub